PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISAESE (MASLD)-RELATED CIRRHOSIS IN THE UNITED STATES

被引：0
|
作者：
Owrangi, Soroor
Hashida, Ryuki
Paik, James M.
Golabi, Pegah
De Avila, Leyla
Younossi, Zobair M.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1580
引用
收藏
页码：S1648 / S1649
页数：2
相关论文
共 50 条
  • [41] Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States
    Gawrieh, Samer
    Vilar-Gomez, Eduardo
    Woreta, Tinsay A.
    Lake, Jordan E.
    Wilson, Laura A.
    Price, Jennifer C.
    Naggie, Susanna
    Sterling, Richard K.
    Heath, Sonya
    Corey, Kathleen E.
    Cachay, Edward R.
    Ajmera, Veeral
    Tonascia, James
    Sulkowski, Mark S.
    Chalasani, Naga
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (05) : 666 - 679
  • [42] RISK OF HEPATIC DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC FATTY LIVER (NAFLD)-RELATED CIRRHOSIS
    Hernaez, Ruben
    Yu, Xian
    Kramer, Jennifer R.
    El-Serag, Hashem B.
    Kanwal, Fasiha
    GASTROENTEROLOGY, 2019, 156 (06) : S1217 - S1218
  • [43] Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
    Mittal, Sahil
    El-Serag, Hashem B.
    Sada, Yvonne H.
    Kanwal, Fasiha
    Duan, Zhigang
    Temple, Sarah
    May, Sarah B.
    Kramer, Jennifer R.
    Richardson, Peter A.
    Davila, Jessica A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (01) : 124 - +
  • [44] SOCIAL VULNERABILITY (SV) IS ASSOCIATED WITH HIGHER PREMATURE MORTALITY FROM METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN THE UNITED STATES (US)
    Paik, James
    Henry, Linda
    Paik, Annette
    Zelber-Sagi, Shira
    Kugelmas, Carina
    Lazarus, Jeffrey
    de Avila, Leyla
    Gerber, Lynn
    Younossi, Zobair
    HEPATOLOGY, 2024, 80 : S696 - S697
  • [45] Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Elshaer, Amani
    Chascsa, David M. H.
    Lizaola-Mayo, Blanca C.
    LIFE-BASEL, 2024, 14 (07):
  • [46] Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Markowska, Julia
    Kasprzak-Drozd, Kamila
    Nizinski, Przemyslaw
    Dragan, Magdalena
    Kondracka, Adrianna
    Gondek, Ewa
    Oniszczuk, Tomasz
    Oniszczuk, Anna
    MOLECULES, 2024, 29 (22):
  • [47] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
    Chan, Wah-Kheong
    Chuah, Kee-Huat
    Rajaram, Ruveena Bhavani
    Lim, Lee-Ling
    Ratnasingam, Jeyakantha
    Vethakkan, Shireene Ratna
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (03) : 197 - 213
  • [48] EATING DISORDERS IN MEXICAN POPULATION WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Contreras, Ana D. Cano
    Alvarez, Hector Ricardo Ordaz
    Priego-Parra, Bryan Adrian
    Martinez-Perez, Genesis Patricia
    Reyes-Diaz, Sara A.
    Azamar, Pamela Duran
    Garcia-Carvajal, Mario J.
    Diaz-Crespo, Angel H.
    Vazquez-Cruz, Anette P.
    Hernandez, Tonatiu Castellanos
    Basurto, Jose Luis Vargas
    Dietlen, Federico B. Roesch
    Francisco, Maria D.
    Amieva-Balmori, Mercedes
    Remes-Troche, Jose Maria
    GASTROENTEROLOGY, 2024, 166 (05) : S1649 - S1650
  • [49] Environment, Endocrine Disruptors, and Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD)
    Mosca, Antonella
    Manco, Melania
    Braghini, Maria Rita
    Cianfarani, Stefano
    Maggiore, Giuseppe
    Alisi, Anna
    Vania, Andrea
    METABOLITES, 2024, 14 (01)
  • [50] Factors associated with steatotic liver disease associated with metabolic dysfunction (MASLD) in patients with Inflammatory Bowel Disease (IBD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i871 - i871
12345